Transcription of （NCCN腫瘍学臨床診療ガイドライン） 原 発 不 明 が ん
1 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) CUP 2019 2 2019 1 23 2 01/23/2019 2019 National Comprehensive Cancer Network (NCCN ). NCCN NCCN 2019 2 01/23/2019 2019 National Comprehensive Cancer Network (NCCN ). NCCN NCCN Guidelines Version NCCN / / / ф / * *David S.
2 Ettinger, MD/Chair The Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsGauri R. Varadhachary, MD/Vice-Chair The University of Texas MD Anderson Cancer CenterDaniel W. Bowles, MD University of Colorado Cancer CenterJeremiah Deneve, DO St. Jude Children s Research Hospital/ University of Tennessee Health Science CenterMihaela Druta, MD Moffitt Cancer CenterKeith D. Eaton, MD, PhD Fred Hutchinson Cancer Research Center/Seattle Cancer Center AllianceJoseph Gibbons, MD Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute David Gierada, MD фSiteman Cancer Center at Barnes-Jewish Hospital and Washington University School of MedicineG.
3 Weldon Gilcrease, MD Huntsman Cancer Institute at the University of UtahKelly Godby, MD University of Alabama at Birmingham Comprehensive Cancer CenterAngela Jain, MD Fox Chase Cancer CenterChristina Kong, MD Stanford Cancer InstituteJeremy Kortmansky, MD Yale Cancer Center/Smilow Cancer HospitalRenato Lenzi, MD The University of Texas MD Anderson Cancer CenterSam Lubner, MD University of Wisconsin Carbone Cancer CenterMartin C. Mahoney, MD, PhD Roswell Park Comprehensive Cancer CenterJohn Phay, MD The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute Asif Rashid, MD The University of Texas MD Anderson Cancer CenterKerry Reynolds, MD Dana-Farber Cancer/Brigham and Women's Cancer Center I Massachusetts General Hospital Cancer Center Leonard Saltz, MD Memorial Sloan Kettering Cancer Center Richard B.
4 Schwab, MD UC San Diego Moores Cancer CenterChanjuan Shi, MD, PhD Vanderbilt-Ingram Cancer CenterJeffrey B. Smerage, MD, PhD University of Michigan Rogel Cancer CenterMarvaretta M. Stevenson, MD Duke Cancer InstituteDaphne B. Stewart, MD, MS City of Hope Comprehensive Cancer CenterHarry H. Yoon, MD Mayo Clinic Cancer CenterMatthew B. Yurgelun, MD Dana-Farber Cancer/Brigham and Women's Cancer Center I Massachusetts General Hospital Cancer Center Weining (Ken) Zhen, MD Fred & Pamela Buffett Cancer CenterNCCNMary Anne BergmanLenora A.
5 Pluchino, PhD* NCCN NCCN : 2A NCCN NCCN OCC-1 OCC-2 OCC-3 OCC-11 OCC-16 OCC-A OCC-B OCC-C NCCN NCCN National Comprehensive Cancer Network NCCN NCCN
6 National Comprehensive Cancer Network NCCN NCCN 20192019 2 01/23/2019 2019 National Comprehensive Cancer Network (NCCN ). NCCN NCCN Guidelines Version 2019 2 01/23/2019 2019 National Comprehensive Cancer Network (NCCN ). NCCN UPDATESNCCN Guidelines Version 2019 1 2019 2 OCC-A 1 of 5: TRK NGS Drilon A, Laetsch TW, Kummar S, et al.
7 Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children. N Engl J Med 2018;378 2019 1 2019 2 MS-1 OCC-1 MSI/MMR MSI-high/MMR MSI-H/dMMR MMR IHC MSI PCR OCC-9 4 2B OCC-A 1 of 5: PAX8 4 of 5: CK7 p53 CDX2 p16 SATB2 5 of 5.
8 CEA OCC-B 2 of 4 175 200mg/m2/ AUC=5 6 1000 1250mg/m2/ 75100mg/mm2 FOLFIRI 5 NCCN Guidelines Version 2019 2 01/23/2019 2019 National Comprehensive Cancer Network (NCCN ). NCCN 2A NCCN OCC-1a NCCN Guidelines for Distress Management b CT/MRI c MSI-high/MMR MSI-H/dMMR MMR IHC MSI PCR
9 D OCC-A e 3 a / / CT b MSI/MMR c / FNA d e OCC-2 NCCN Guidelines Table of Contents NCCN Guidelines for Thyroid Carcinoma NCCN NCCN Guidelines for Soft Tissue Sarcoma NCCN NCCN Guidelines Version 2019 2 01/23/2019 2019 National Comprehensive Cancer Network (NCCN ).
10 NCCN 2A NCCN OCC-2 OCC-3 OCC-4 OCC-5 OCC-6 OCC-11 NCCN Guidelines for Neuroendocrine Tumors NCCN Guidelines Version 2019 2 01/23/2019 2019 National Comprehensive Cancer Network (NCCN ).
